In every industry their is always the endless search to find ‘the-next-BIG-thing', and cell culture vaccine production is no different! Cell lines from African green monkey to carrots, and Chinese hamster ovary to tobacco have been investigated with varying degrees of success. Now, Baxter have published results on a novel avian cell line, while at the University of Arizona, Dr …
#Vaccine production with #non-mammalian #cell-lines
Is vaccine production using non-mammalian cell-lines going to become the dominate force over the next 3 years? It is known that the vast majority of experience and regulatory history of using cell culture to produce vaccines is with mammalian cell-lines, but is it time for change? Is it economically viable to stop using mammalian cell lines for vaccine production or …
#Pfizer #Vaccine Research discuss developing stable packaging #cell lines and processes
Dr Mohinder Sidhu, Senior Director at Pfizer Vaccine Research has over 20 years of experience in viral and bacterial vaccines R&D. His major research interests have been focused on the development of vaccines against negative strand RNA viruses (NSV) including human respiratory syncytial virus, human parainfluenza viruses, measles virus, mumps virus and influenza viruses as well as the use of …
Can #bio-informatic analysis deliver #vaccine #cell line qualification?
One of the biggest challenges standing in the way of cell culture vaccine production is achieving cell line qualification, and standing in the way of this is proving you have scanned for all known and unknown pathogens throughout bio-production. In April the leading players working to try to achieve this goal are going to be in Washington D.C. discussing their …